Sun et al. reported that the use of sialic acid-targeted nanoparticles delivering CSF-1R siRNA resulted in the reprogramming of macrophages to the M1 phenotype in human and mouse PC models [108]. This evidence concerns the gene CSF1R and pachyonychia congenita.